dexmedetomidine has been researched along with Bipolar Disorder in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Citrome, L; De Vivo, M; Fava, M; Finman, J; Goldberg, JF; Kakar, R; Preskorn, SH; Risinger, R; Yocca, FD; Zeller, S | 1 |
| Preskorn, SH | 1 |
| Kakar, R; Preskorn, SH; Risinger, R | 1 |
| Dantz, B; Henry, PH | 1 |
| Abe, A; Ishiki, H; Takeda, Y | 1 |
| Citrome, L; Rajachandran, L; Risinger, R; Robison, H | 1 |
| Citrome, L; Ward, K | 1 |
| Bulut, M; Ganidagli, S; Koruk, S; Mizrak, A; Oner, U | 1 |
| Ackerman, AL; Mount, C | 1 |
1 review(s) available for dexmedetomidine and Bipolar Disorder
| Article | Year |
|---|---|
The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy.
Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Drug Development; Drugs, Investigational; Humans; Olanzapine; Psychomotor Agitation; Schizophrenia | 2020 |
3 trial(s) available for dexmedetomidine and Bipolar Disorder
| Article | Year |
|---|---|
Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial.
Topics: Administration, Sublingual; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Bipolar Disorder; Dexmedetomidine; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychomotor Agitation | 2022 |
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Double-Blind Method; Humans; Schizophrenia; Treatment Outcome | 2022 |
Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
Topics: Adult; Anesthesia; Bipolar Disorder; Blood Pressure; Depressive Disorder, Major; Dexmedetomidine; Electroconvulsive Therapy; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Premedication; Propofol; Psychomotor Agitation; Respiratory Insufficiency; Seizures | 2009 |
5 other study(ies) available for dexmedetomidine and Bipolar Disorder
| Article | Year |
|---|---|
How an Understanding of the Function of the Locus Coeruleus Led to Use of Dexmedetomidine to Treat Agitation in Bipolar Disorder: Example of Rational Development of Psychiatric Medications.
Topics: Adrenergic alpha-2 Receptor Agonists; Anxiety; Bipolar Disorder; Dexmedetomidine; Humans; Locus Coeruleus | 2022 |
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply.
Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation | 2022 |
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation | 2022 |
Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder.
Topics: Administration, Sublingual; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Humans; Hypnotics and Sedatives; Psychomotor Agitation | 2022 |
Successful treatment of acute mania and perineal abscess using dexmedetomidine sedation as adjunctive therapy.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antipsychotic Agents; Bipolar Disorder; Dexmedetomidine; Diagnosis, Differential; Humans; Hypnotics and Sedatives; Male; Medication Adherence; Rectal Diseases; Ultrasonography | 2011 |